| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |